Measuring medication: Do interviews agree with medical record and pharmacy data?

Medical Care

Volumn 40, Issue 12, 2002, Pages 1270-1282

  Korthuis, P Todd ^a,f   Asch, Steven ^a,b   Mancewicz, Martha ^b   Shapiro, Martin F ^a,b   Mathews, W Christopher ^c   Cunningham, William E ^a,b   Mccutchan, J Allen ^c   Gifford, Allen ^c,d   Lee, Martin L ^a,e   Bozzette, Samuel A ^b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e Center for the Study of Healthcare Provider Behavior   (United States)

^f VA Greater Los Angeles Healthcare Center   (United States)

Author keywords

Cohort studies; Epidemiology; HIV disease AIDS; Medications; Methodology

Indexed keywords

ARTICLE; COMPARATIVE STUDY; DRUG UTILIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MEDICAL RECORD; PROSPECTIVE STUDY; STATISTICS; UNITED STATES;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG UTILIZATION; HIV INFECTIONS; HUMANS; INTERVIEWS; MEDICAL RECORDS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 11244338084     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200212000-00014     Document Type: Article

References (32)

1. Brook RH, Appel FA. Quality-of-care assessment: choosing a method of peer review. N Engl J Med 1973;288:1323-1329.
2. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients -results of the Harvard Medical Practice Study I. N Engl J Med 1991;324:370-376.
3. Bates DW, Cullen DJ, Laird NM, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995;274:29-34.
4. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: Results from the HIV cost and services utilization study. JAMA 1999;281:2305-2375.5. Sleath BL, Rubin RH, Huston SA. Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care. Ann Pharmacother 2001;35:419-423.
5. Halkin H, Katzir I, Kurman I, et al. Preventing drug interactions by online prescription screening in community pharmacies and medical practices. Butterworth's Int Med Rev Clin Pharmacol Ther 2001;69:260-265.
6. Fijn R, Stuurman-Bieze AG, van den Berg PB, et al. Predictors for prophylactic antithrombotic prescribing in ischaemic heart disease and the impact of national guidelines. Eur J Clin Pharmacol 2000;56:739-746.
7. Simon GE, Von Korff M, Rutter CM, et al. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Psychiatry 2001;58:395-401.
8. Andersen R, Bozzette S, Shapiro M, et al. Access of Vulnerable Groups to Antiretroviral Therapy Among Persons in Care for HIV Disease in the United States. Health Serv Res 2000;35:389-416.
9. Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. JAIDS 2000;25:115-123.
10. Graham NM, Jacobson LP, Kuo V, et al. Access to therapy for HIV disease in the Multicenter AIDS Cohort Study. J Clin Epidemiol 1994;47:1003-1012.
11. Moore RD Stanton D, Gopalan R, et al. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med 1994;330:763-768.
12. Shapiro MF, Berk ML, Berry SH, et al. National probability samples in studies of low-prevalence diseases. Part I: Perspectives and lessons from the HIV Cost and Services Utilization Study. Health Serv Res 1999;34:951-968.
13. Frankel MR, Shapiro MF, Duan N, et al. National probability samples in studies of lowprevalence diseases. Part II: Designing and implementing the HIV Cost and Services Utilization Study sample. Health Serv Res 1999;34:969-992.
14. Berry SH, Brown JA, Athey L, et al. HCSUS Baseline patient questionnaire documentation. Santa Monica, CA: RAND; 1998. MR-1090-AHCPR:
15. Smith SM, Halverson ML, Broach RJ, et al. HCSUS records collection draft methodology report. National Opinion Research Center (NORC), Chicago, IL, December 9,1999.
16. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR 1998;47(RR-5):43-82.
17. Cicchetti DV, Feinstein AR. High agreement but low kappa II. Resolving the paradoxes. J Clin Epidemiol 1990;43:551-558.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
19. Fleiss JL. Statistical Methods for Rates and Proportions, 2nd ed. New York, NY: John Wiley and Sons; 1981.
20. Agresti A. Categorical Data Analysis. New York, NY: John Wiley and Sons; 1990:391-393.
21. Horwitz RI, Feinstein AR, Stremlau JR. Alternative data sources and discrepant results in casecontrol studies of estrogens and endometrial cancer. Am J Epidemiol 1980;111:389-394.
22. Cotterchio M, Kreiger N, Darlington G, et al. Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol 1999;9:283-289.
23. Harlow SD, Linet MS. Agreement between questionnaire data and medical records: the evidence for accuracy of recall. Am J Epidemiol 1989;129:233-248.
24. Goodman MT, Nomura AM, Wilkens LR, et al. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990;131:815-825.
25. Westbrook JI, McIntosh JH, Rushworth RL, et al. Agreement between medical record data and patients'accounts of their medical history and treatment for dyspepsia. J Clin Epidemiol 1998;51:237-244.
26. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982;116:114-122.
27. West SL, Strom BL, Freundlich B, et al. Completeness of prescription recording in outpatient medical records from a health maintenance organization. J Clin Epidemiol 1994;47:165-171.
28. West SL, Savitz DA, Koch G, et al. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995;142:1103-1112.
29. Sjahid SI, van der Linden FD, Stricker BH. DJAgreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study. Br J Clin Pharmacol 1998;45:591-595.
30. LaVeist TA. Beyond dummy variables and sample selection: what health services researchers ought to know about race as a variable. Health Serv Res 1994;29:1-16.
31. Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problem of two paradoxes. J Clin Epidemiol 1990;43:543-549.
32. Spengler RF, Clarke EA, Woolever CA, et al. Exogenous estrogens and endometrial cancer: a casecontrol study and assessment of potential biases. Am J Epidemiol 1981;114:497-506.